Fetuin-A, a hepatokine, also contributes to the onset and exacerbation of NAFLD,27 and the circulating Se-P and fetuin-A concentrations are high in patients with NAFLD.26 The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.